Accès ouvert
2026
other
OpenAlex
Fatoumatta Dibba
Extensive scholarly research exists on the impact of IUU fishing and Industrial fishmeal production on the environment, local food systems, labour markets, as well as on the socio-economic well-being of artisanal fisherfolk in general. However, there exist minimal scholarly work on the …
Accès ouvert
2025
article
OpenAlex
Ryan Curtin, Yogambigai Velmurugu, Fatoumatta Dibba, Hao Yuan et autres
Background: There is a greater risk of complications from severe COVID-19 in immunocompromised patients with multiple sclerosis (pwMS) treated with certain disease-modifying therapies (DMTs), as well as a diminished vaccine response. Methods: In this exploratory, observational study, we recruited 28 patients with …
us
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Ryan Curtin, Yogambigai Velmurugu, Fatoumatta Dibba, Hao Yuan et autres
Abstract Background and Objectives Patients with multiple sclerosis (pwMS) treated with ocrelizumab (OCR), a B-cell-depleting therapy, exhibit heterogeneous humoral responses to SARS-CoV-2 mRNA vaccination. The mechanisms underlying this variability remain incompletely understood. We performed a longitudinal analysis of B-cell subset dynamics and …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Aswin Natarajan, Yogambigai Velmurugu, Manuel Becerra Flores, Fatoumatta Dibba et autres
The extracellular molecular organization of the individual CD3 subunits around the αβ T cell receptor (TCR) is critical for initiating T cell signaling. In this study, we incorporate photo-crosslinkers at specific sites within the TCRα, TCRβ, CD3δ, and CD3γ subunits. Through crosslinking …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Ilya Kister, Ryan Curtin, Jinglan Pei, Katherine Perdomo et autres
OBJECTIVE: To compare "hybrid immunity" (prior COVID-19 infection plus vaccination) and post-vaccination immunity to SARS CoV-2 in MS patients on different disease-modifying therapies (DMTs) and to assess the impact of vaccine product and race/ethnicity on post-vaccination immune responses. METHODS: Consecutive MS patients …
us, ch
(code pays fourni par la source)
Accès ouvert
2022
preprint
OpenAlex
Ilya Kister, Ryan Curtin, Jinglan Pei, Katherine Perdomo et autres
Abstract Objective To compare ‘hybrid immunity’ (prior COVID-19 infection plus vaccination) and post-vaccination immunity to SARS CoV-2 in MS patients on different disease-modifying therapies (DMTs) and to assess the impact of vaccine product and race/ethnicity on post-vaccination immune responses. Methods Consecutive MS …
us, ch
(code pays fourni par la source)
2018
article
OpenAlex
Sunkaru Touray, Baboucarr Sanyang, Gregory Zandrow, Fatoumatta Dibba et autres
us, Gambie
(code pays fourni par la source)